Serological paroteomic biomarkers for monitoring liver fibrosis regression in on-treatment hepatities b patients

ABSTRACT: Paired serological proteomes from CHB patients undergoing short-term and long-term anti-viral treatment were profiled using PRM-based proteomics technology.The serological proteomic landscapes following AVT were systematically analyzed and compared between fibrosis regressors and non-regressors.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell, Blood Plasma

DISEASE(S): Hepatitis B

SUBMITTER: Mengyang Zhang  

LAB HEAD: Hong You

PROVIDER: PXD063833 | Pride | 2025-08-25

REPOSITORIES: Pride